Lidocaine Hci NDC 51662-1233

NDC codes

FDA NDC Directory

Product NDC (as listed)51662-1233Labeler and product segments. Claims need a package NDC.

Product NDC at billing width51662-1233Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
51662-1233-1	51662123301	5 mL in 1 VIAL, SINGLE-DOSE (51662-1233-1)Marketed from Jun 28, 2019
51662-1233-2	51662123302	1 VIAL, SINGLE-DOSE in 1 POUCH (51662-1233-2) / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 22, 2021
51662-1233-3	51662123303	20 POUCH in 1 CASE (51662-1233-3) / 1 VIAL, SINGLE-DOSE in 1 POUCH / 5 mL in 1 VIAL, SINGLE-DOSEMarketed from Jan 22, 2021

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lidocaine Hci
Generic name (nonproprietary): lidocaine hci
Active ingredients: Lidocaine hydrochloride — 20 mg/mL
Dosage form: Injection, Solution
Route: Epidural, Infiltration, Intracaudal, Perineural
Labeler: HF Acquisition Co LLC, DBA HealthFirst
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 040078
Marketing start: Jun 28, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Amides (Chemical structure)Local Anesthesia (Physiologic effect)
Identifiers: Product ID 51662-1233_10328ddf-6e36-c9e0-e063-6294a90a52edSPL ID 10328ddf-6e36-c9e0-e063-6294a90a52edSPL set ID 8c63be55-5de4-7f72-e053-2995a90a102eRxCUI 1737761UNII V13007Z41A
Pharmacologic class: Amide Local Anesthetic; Antiarrhythmic

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N451662123301 followed by a unit qualifier and the quantity

Package 51662-1233-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 30, 2024.

Indications (excerpt from the label)

INDICATIONS & USAGE Lidocaine HCl injection is indicated for production of local or regional anesthesia by infiltration techniques such as percutaneous injection and by peripheral nerve block techniques such as brachial plexus and intercostal and by central neural techniques such as lumbar and caudal epidural blocks, when the accepted procedures for these techniques as described in standard textbooks are observed.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 040078

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040078
Product	Strength	Form · route	Labeler	Product NDC
Lidocaine Hydrochloride	Lidocaine hydrochloride 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	Hospira, Inc.	0409-2066
Lidocaine Hydrochloride	Lidocaine hydrochloride 20 mg/mL	Injection, SolutionEpidural, Infiltration, Intracaudal, Perineural	ProPharma Distribution	84549-066